Filewrapper-old |
Pharmaceutical giant GlaxoSmithKline filed a lawsuit in the Eastern District of Virginia seeking to stop implementation of the new continuation and claim limit rules. The lawsuit, filed Tuesday, seeks a preliminary and permanent injunction against the rules' implementation. The complaint has eight counts:
Click here to read the full complaint. With the power and motivation of a pharmaceutical giant like GlaxoSmithKline, the lawsuit will certainly be vigorously pursued, particularly given that pharmaceutical and biotech patents will be the most adversely affected by the new rules.
Hat tip to Gene Quinn at the PLI Patent Law Blog, who also provided the copy of the complaint.
Update (10/12): The Wall Street Journal Law Blog has picked up the story, and has a call in to the USPTO for comment. It will be interesting to see what the Office has to say.
The attorneys of McKee, Voorhees & Sease, P.L.C. designed this blog as an informational and educational resource about intellectual property law for our clients, other attorneys, and the public as a whole. Our goal is to provide cutting-edge information about recent developments in intellectual property law, including relevant case law updates, proposed legislation, and intellectual property law in the news.
McKee, Voorhees & Sease, P.L.C. provides this blog for general informational purposes only. By using this blog, you agree that the information on this blog does not constitute legal or other professional advice and no attorney-client or other relationship is created between you and McKee, Voorhees & Sease, P.L.C. Do not consider this blog to be a substitute for obtaining legal advice from a qualified, licensed attorney. While we try to revise this blog on a regular basis, it may not reflect the most current legal developments. We consciously refrain from expressing opinions on this blog and instead, offer it as a form of information and education, however if there appears an expression of opinion, realize that those views are indicative of the individual and not of the firm as a whole
Your Worldwide IP Partner since 1924 ™Services |